Article
- The EMBO Journal (2002) 21, 4831 - 4840
- doi:10.1093/emboj/cdf478
Subject Categories:
Induction of COX-2 by LPS in macrophages is regulated by Tpl2-dependent CREB activation signals
Aristides G. Eliopoulos1,2, Calin D. Dumitru1, Chun-Chi Wang1, Jeonghee Cho1 and Philip N. Tsichlis1,3
- Kimmel Cancer Center, Department of Microbiology and Immunology, Thomas Jefferson University, Philadelphia, PA 19107, USA
- Cancer Research UK Institute for Cancer Studies and MRC Center for Immune Regulation, The University of Birmingham Medical School, Birmingham B15 2TA, UK
- Present address: Tufts—New England Medical Center, Molecular Oncology Research Institute, 750 Washington Street, #5609, Boston, MA 02111, USA
Correspondence to:
Philip N. Tsichlis, E-mail: ptsichlis@lifespan.org
Received 8 January 2002; Accepted 19 July 2002; Revised 12 June 2002
Abstract
Macrophage activation by bacterial lipopolysaccharide (LPS) promotes the secretion of pro-inflammatory cytokines, such as tumor necrosis factor-
(TNF-
) and interleukin-1
(IL-1
), and of secondary mediators, such as leukotrienes and prostaglandins (PGs). Mice lacking the gene encoding the serine/threonine protein kinase Tpl2/Cot produce low levels of TNF-
in response to LPS because of an ERK-dependent post-transcriptional defect, and they are resistant to LPS/D-galactosamine-induced endotoxin shock. In this study we demonstrate that prostaglandin E2 and its regulatory enzyme, COX-2, are also targets of Tpl2-transduced LPS signals in bone marrow-derived mouse macrophages. Thus, LPS-stimulated Tpl2-/- macrophages express low levels of COX-2 and PGE2, compared with wild-type Tpl2+/+ cells. The ability of Tpl2 to regulate COX-2 expression depends on ERK signals that activate p90Rsk and Msk1, which in turn phosphorylate CREB, a key regulator of COX-2 transcription. These data identify physiological targets of Tpl2 signaling downstream of ERK and further implicate Tpl2 in the pathophysiology of inflammation.
Keywords:
- Cot,
- COX-2,
- LPS,
- signaling,
- Tpl2



